产品货号：
Z35854
中文名称：
PD-L1/CD274抗体
英文名称：
Anti-PD-L1/CD274 Antibody (Clone#6H10)
产品规格：
0.1mg
发货周期：
1～3天
产品价格：
询价
| 抗体名称 | Anti-PD-L1/CD274 Antibody (Clone#6H10) |
| 指标别名 | B7 H;B7 H1;B7 homolog 1;B7H1;CD274;CD274 molecule;PD L1;PDCD1 ligand 1;PDCD1L1;PDCD1LG1;PDL1;PD-L1;PD-L1/CD274;Programmed death ligand 1 |
| 克隆性 | Monoclonal |
| 检验物种 | human,mouse |
| 应用范围 | ELISA,WB,IHC,ICC,IF |
| 基因名称 | CD274 |
| 克隆号 | 6H10 |
| 抗体来源 | Mouse |
| 抗体类型 | IgG1 |
| 免疫原 | Anti-PD-L1 antibody was raised against the extracellular domain of human PD-L1. |
| 计算分子量 | 33kDa |
| 成分 | PD-L1 Antibody is supplied in PBS containing 0.02% sodium azide and 50% glycerol. |
| 纯化方式 | PD-L1 Antibody is supplied as protein A purified IgG1. |
| 浓度 | 1mg/mL |
| 产品形态 | 溶液 |
| 保存条件 | 4℃可保存3个月，-20℃可保存1年。 |
| 背景资料 | PD-L1 plays a critical role in induction and maintenance of immune tolerance to self.As a ligand for the inhibitory receptor PDCD1/CD279,PD-L1 modulates the activation threshold of T-cells and limits T-cell effector response (1).The PDCD1/CD279-mediated inhibitory pathway is exploited by tumors to attenuate anti-tumor immunity and facilitate tumor survival (2,3).Through a yet unknown activating receptor,it may costimulate T-cell subsets that predominantly produce interleukin-10 (IL10) (4). |
| Uniprot ID | Q9NZQ7 |
| 基因名全称 | Programmed cell death 1 ligand |
| 蛋白名全称 | Programmed cell death 1 ligand |
| 推荐稀释比 | WB:0.25 ～ 4μg/mL;IF:2μg/mL;IHC:5μg/mL;ICC:1μg/mL.Antibody validated:Western Blot in human and mouse samples;Immunohistochemistry,Immunocytochemistry and Immunofluorescence in human samples.All other applications and species not yet tested. |
相关搜索：PD-L1/CD274抗体，PD-L1抗体，CD274单抗，Anti-PD-L1/CD274 Antibody (Clone#6H10)